Table 1 Demographic characteristics of the study population
From: Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation
Patient characteristics | TG (n = 43) | non-TG (n = 43) | P value |
|---|---|---|---|
Mean age (years) | 42.88 ± 10.99 | 41.81 ± 8.91 | 0.356 |
Male (%) | 34 (79.1%) | 29 (67.4%) | 0.330 |
Primary disease (%) | |||
 CGN | 31 (72.1%) | 35 (81.4%) | 0.444 |
 DN | 1 (2.3%) | 0 | 1.0 |
 IgAN | 2 (4.7%) | 2 (4.7%) | 1.0 |
 FSGS | 2 (4.7%) | 1 (3.3%) | 1.0 |
 Alport syndrome | 0 | 2 (4.7%) | 0.494 |
 Others | 7 (16.3%) | 3 (7.0%) | 0.313 |
Time from transplant to biopsy (years) | 4.93 ± 2.72 | 4.53 ± 2.52 | 0.772 |
Immunosuppressive regimen (%) | |||
 CMP | 20 (46.5%) | 26 (60.5%) | 0.28 |
 FMP | 19 (44.2%) | 13 (30.2%) | 0.265 |
 CAP | 3 (7.0%) | 4 (9.3%) | 1.0 |
 Other | 1 (2.3%) | 0 | 1.0 |